HISVX | VSCIX | HISVX / VSCIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 22 years | 28 years | - |
Gain YTD | -2.320 | 2.397 | -97% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.46B | 161B | 2% |
Annual Yield % from dividends | 0.33 | 1.43 | 23% |
Returns for 1 year | 8.78 | 14.26 | 62% |
Returns for 3 years | 1.99 | 22.08 | 9% |
Returns for 5 years | 18.02 | 48.39 | 37% |
Returns for 10 years | 49.37 | 111.39 | 44% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSELX | 20.99 | -0.02 | -0.10% |
Morgan Stanley Inst Emerging Mkts L | |||
NSBCX | 62.66 | -0.73 | -1.15% |
Nuveen Dividend Growth C | |||
FAPLX | 13.05 | -0.19 | -1.44% |
Fidelity Advisor Healthy Future M | |||
SCSIX | 38.32 | -0.98 | -2.49% |
Sterling Capital SmCp Val R6 | |||
TFOIX | 42.87 | -1.42 | -3.21% |
Transamerica Capital Growth I |